ABVC BioPharma, Inc. Proceeds from Contributed Capital
ABVC BioPharma, Inc. (ABVC) reported Proceeds from Contributed Capital of $454.37 thousand for the 1-month period ending 2025-04-30, per its 10-Q filed 2025-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2025-08-13
- 2025-04-30: Proceeds from Contributed Capital 1 month $454.37K.
| Period end | Proceeds from Contributed Capital 1 month |
|---|---|
| 2025-04-30 | $454.37K 10-Q · filed 2025-08-13 |